Andrew Kucharchuk
Director Financiero/CFO en THERALINK TECHNOLOGIES, INC. .
Fortuna: 290 $ al 30/04/2024
Cargos activos de Andrew Kucharchuk
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
THERALINK TECHNOLOGIES, INC. | Director/Miembro de la Junta | 01/09/2015 | - |
Director Financiero/CFO | 08/05/2023 | - | |
Contacto de Relaciones con Inversores | - | - | |
Director Ejecutivo | 08/11/2019 | 05/06/2020 | |
Presidente | 01/09/2015 | 05/06/2020 | |
AVANT DIAGNOSTICS INC | Director/Miembro de la Junta | - | - |
ADHERA THERAPEUTICS, INC. | Director/Miembro de la Junta | 19/05/2022 | - |
Director de Operaciones | 30/09/2022 | - | |
Director Ejecutivo | 07/07/2020 | 30/09/2022 | |
Presidente | 07/07/2020 | 19/05/2022 | |
CHAIN BRIDGE I | Director Financiero/CFO | 01/04/2024 | - |
Kappa Alpha Order | Corporate Officer/Principal | - | - |
Historial de carrera de Andrew Kucharchuk
Antiguos cargos conocidos de Andrew Kucharchuk.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
OncBioMune, Inc.
OncBioMune, Inc. BiotechnologyHealth Technology OncBioMune, Inc. develops biotechnologies for cancer treatment. The company is headquartered in Baton Rouge, LA. | Director/Miembro de la Junta | - | - |
Director Ejecutivo | - | - | |
Director Financiero/CFO | - | - |
Formación de Andrew Kucharchuk.
Louisiana State University | Undergraduate Degree |
A.B. Freeman School of Business | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 9 |
Operativa
Director/Board Member | 4 |
Chief Executive Officer | 3 |
Director of Finance/CFO | 3 |
Sectorial
Health Technology | 5 |
Consumer Services | 3 |
Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
THERALINK TECHNOLOGIES, INC. | Health Technology |
CHAIN BRIDGE I | Finance |
ADHERA THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Kappa Alpha Order | |
OncBioMune, Inc.
OncBioMune, Inc. BiotechnologyHealth Technology OncBioMune, Inc. develops biotechnologies for cancer treatment. The company is headquartered in Baton Rouge, LA. | Health Technology |
Theralink Technologies, Inc. (Colorado)
Theralink Technologies, Inc. (Colorado) Medical SpecialtiesHealth Technology Theralink Technologies, Inc. engages in the provision of biomarker assay services in the areas of oncology. The firm offers personalized medicine data through TheraLink assays to assist the biopharmaceutical industry and clinical oncologists in identifying drug treatments. It develops phosphoproteomic technologies that measure the activation status of signaling pathways. The company was founded on October 16, 2008 and is headquartered in Golden, CO. | Health Technology |
- Bolsa de valores
- Insiders
- Andrew Kucharchuk
- Experiencia